FDA Orange Book · active-ingredient family
Neomycin sulfate; prednisolone acetate
Neomycin sulfate; prednisolone acetate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
0
Brand (NDA)
2
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Generic (ANDA) products (2)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| NEO-DELTA-CORTEF×2 | PHARMACIA AND UPJOHN | ANDA 061039 | — | Approved Prior to Jan 1, 1982 | |
| NEO-DELTA-CORTEF | PHARMACIA AND UPJOHN | ANDA 061037 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Neomycin sulfate; prednisolone acetate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
